גרדסיל ישראל - עברית - Ministry of Health

גרדסיל

merck sharp & dohme israel ltd - protein l1 (type 11); protein l1 (type 16); protein l1 (type 18); protein l1 (type 6) - תרחיף להזרקה - protein l1 (type 18) 20 mcg / 0.5 ml; protein l1 (type 6) 20 mcg / 0.5 ml; protein l1 (type 11) 40 mcg / 0.5 ml; protein l1 (type 16) 40 mcg / 0.5 ml - combinations - combinations - gardasil is indicated in females aged 9 through 45 years* for the prevention of cervical, vulvar, vaginal cancer, precancerous or dysplastic lesions, genital warts, and infection caused by human papillomavirus (hpv) types 6, 11, 16, and 18 (which are included in the vaccine). gardasil is indicated in males 9 through 26 years* of age for the prevention of anal cancer, precancerous or dysplastic lesions, external genital lesions and infection caused by hpv types 6, 11, 16, and 18 (which are included in the vaccine). *immunogenicity studies have been conducted to link efficacy in females and males aged 16 to 26 years to the younger populations..

קונקור 10 מג ישראל - עברית - Ministry of Health

קונקור 10 מג

merck serono ltd - bisoprolol fumarate - טבליה - bisoprolol fumarate 10 mg - bisoprolol - bisoprolol - hypertension. coronary heart disease (angina pectoris).

טנסופריל 10 מ"ג ישראל - עברית - Ministry of Health

טנסופריל 10 מ"ג

merck sharp & dohme israel ltd - lisinopril as dihydrate 10 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essentioal hypertension and renovascular hypertension. tensopril may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myorardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction to improve survival.

טנסופריל 20 מ"ג ישראל - עברית - Ministry of Health

טנסופריל 20 מ"ג

merck sharp & dohme israel ltd - lisinopril as dihydrate 20 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essential hypertension and renovascular hypertension. tensopril may be used alone as initial therapy or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myocardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hous of acute myocardial infarction to improve survival.

טנסופריל 5 מ"ג ישראל - עברית - Ministry of Health

טנסופריל 5 מ"ג

merck sharp & dohme israel ltd - lisinopril as dehydrate 5 mg - tablets - lisinopril - hypertension: tensopril is indicated for the treatment of essential hypertension and renovascular hypertension.tensopril may be used alone as initial therapy, or concomitantly with other classes of antihypertensive agents. congestive heart failure: tensopril is indicated as adjunctive therapy in the management of heart failure in patients who are not responding adequately to diuretics and digitalis. acute myocardial infarction: tensopril is indicated for the treatment of hemodynamically stable patients within 24 hours of acute myocardial infarction to improve survival.

אוקסאאר 12.5 מ"ג ישראל - עברית - Ministry of Health

אוקסאאר 12.5 מ"ג

merck sharp & dohme israel ltd - losartan potassium 12.5 mg - tablets - losartan - hypertension: ocsaar is indicated for the treatment of hypertension. heart failure: ocsaar is indicated for the treatment of heart failure (nyha ii) when treatment with an ace inhibitor is no longer considered appropriate. switching patients with heart failure who are stable on an ace inhibitor to ocsaar is not recommended.

סימוביל 40 מ"ג ישראל - עברית - Ministry of Health

סימוביל 40 מ"ג

merck sharp & dohme israel ltd - simvastatin 40 mg - tablets - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simovil is indicated to: reduce the risk of total mortality by reducing coronary death; reduce the risk of non-fatal myocardial infarction; reduce the risk for undergoing myocardial revascularization procedures; reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simovil is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simovil therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglycerid

סימוביל 20 מ"ג ישראל - עברית - Ministry of Health

סימוביל 20 מ"ג

merck sharp & dohme israel ltd - simvastatin 20 mg - tablets - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simovil is indicated to: reduce the risk of total mortality by reducing coronary death; reduce the risk of non-fatal myocardial infarction; reduce the risk for undergoing myocardial revascularization procedures; reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simovil is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simovil therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglycerid

סימוביל 10 מ"ג ישראל - עברית - Ministry of Health

סימוביל 10 מ"ג

merck sharp & dohme israel ltd - simvastatin 10 mg - tablets - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simovil is indicated to: reduce the risk of total mortality by reducing coronary death; reduce the risk of non-fatal myocardial infarction; reduce the risk for undergoing myocardial revascularization procedures;reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simovil is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia( heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simovil therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simovil is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to these measures is inadequate. hypertriglyceride

אינג'י 10 מ"ג/10 מ"ג טבליות ישראל - עברית - Ministry of Health

אינג'י 10 מ"ג/10 מ"ג טבליות

merck sharp & dohme israel ltd - ezetimibe 10 mg; simvastatin 10 mg - tablets - simvastatin - hypercholesterolemia: inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. inegy contains ezetimibe and simvastatin. simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. homozygous familial hypercholesterolemia (hofh): inegy is indicated as adjunctive therapy to diet for use in patients with hofh.patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [ldl] apheresis).